101
Views
9
CrossRef citations to date
0
Altmetric
Original Articles: Research

Random serum methotrexate determinations for assessing compliance with maintenance therapy for childhood acute lymphoblastic leukemia

, , , &
Pages 1843-1847 | Received 25 Jun 2009, Accepted 27 Jul 2009, Published online: 08 Oct 2009

References

  • de Oliveira BM, Viana MB, Zani CL, Romanha AJ. Clinical and laboratory evaluation of compliance in acute lymphoblastic leukaemia. Arch Dis Child 2004;89:785–788.
  • Ribeiro R, Pui CH. Treatment of acute lymphoblastic leukemia in low- and middle-income countries: challenges and opportunities. Leuk Lymphoma 2008;49:373–376.
  • Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet 2008;371:1030–1043.
  • Viana MB, Fernandes RA, de Oliveira BM, Murao M, de Andrade Paes C, Duarte AA. Nutritional and socio-economic status in the prognosis of childhood acute lymphoblastic leukemia. Haematologica 2001;86:113–120.
  • Davies HA, Lilleyman JS. Compliance with oral chemotherapy in childhood lymphoblastic leukaemia. Cancer Treat Rev 1995;21:93–103.
  • Pritchard MT, Butow PN, Stevens MM, Duley JA. Understanding medication adherence in pediatric acute lymphoblastic leukemia: a review. J Pediatr Hematol Oncol 2006;28:816–823.
  • Balis FM, Holcenberg JS, Poplack DG, et al Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch study. Blood 1998;92:3569–3577.
  • Schmiegelow K, Schroder H, Pulczynska MK, Hejl M. Maintenance chemotherapy for childhood acute lymphoblastic leukemia: relation of bone-marrow and hepatotoxicity to the concentration of methotrexate in erythrocytes. Cancer Chemother Pharmacol 1989;25:65–69.
  • Tebbi CK, Cummings KM, Zevon MA, Smith L, Richards M, Mallon J. Compliance of pediatric and adolescent cancer patients. Cancer 1986;58:1179–1184.
  • Matsui DM. Drug compliance in pediatrics. Clinical and research issues. Pediatr Clin North Am 1997;44:1–14.
  • Lilleyman JS, Lennard L. Non-compliance with oral chemotherapy in childhood leukaemia. BMJ 1996;313:1219–1220.
  • Windebank KP, Spinetta JJ. Do as I say or die: compliance in adolescents with cancer. Pediatr Blood Cancer 2008;50:1099–1100.
  • Barr R. Care of teenagers with cancer: a North American perspective. In: Eden TOB, Barr RD, Bleyer A, Whiteson M, editors. Cancer and the Adolescent, 2nd edn. Oxford: Blackwell Publishing; 2005.
  • Spinetta JJ, Masera G, Eden T, et al Refusal, non-compliance, and abandonment of treatment in children and adolescents with cancer: a report of the SIOP Working Committee on Phychosocial Issues in Pediatric Oncology. Med Pediatr Oncol 2002;38:114–117.
  • Partridge AH, Avorn J, Wang PS, Winer EP. Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst 2002;94:652–661.
  • Hande KR. Principles and pharmacology of chemotherapy. In: Greer JP, Foerster J, Rodgers GM, et al editors. Wintrobe's Clinical Hematology, 12th edn. Philadelphia, PA: Lippincott Williams and Wilkins; 2009. pp 1694–1720.
  • Pinkerton CR, Welshman SG, Kelly JG, Shanks RG, Bridges JM. Pharmacokinetics of low-dose methotrexate in children receiving maintenance therapy for acute lymphoblastic leukaemia. Cancer Chemother Pharmacol 1982;10:36–39.
  • Skoglund KA, Soderhall S, Beck O, et al Plasma and urine levels of methotrexate and 7-hydroxymethotrexate in children with ALL during maintenance therapy with weekly oral methotrexate. Med Pediatr Oncol 1994;22:187–193.
  • Balis FM, Savitch JL, Bleyer WA. Pharmacokinetics of oral methotrexate in children. Cancer Res 1983;43:2342–2345.
  • Ravelli A, Di Fuccia G, Molinaro M, et al Plasma levels after oral methotrexate in children with juvenile rheumatoid arthritis. J Rheumatol 1993;20:1573–1577.
  • Hill FG, Richards S, Gibson B, et al Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172). Br J Haematol 2004;124:33–46.
  • Manual. TAO. TDx Abbott Operation Manual. 1996. pp 1–43.
  • Christiansen N, Taylor KM, Duggan C. Oral chemotherapy in paediatric oncology in the UK: problems, perceptions and information needs of parents. Pharmacy World Sci: PWS 2008;30:550–555.
  • Matsui D. Current issues in pediatric medication adherence. Paediatr Drugs 2007;9:283–288.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.